Clinical Trials Directory

Trials / Unknown

UnknownNCT03857113

Technetium Based Radioguided Surgery for Prostate Cancer (TRACE) Study

99mTechnetium Based PSMA-Radioguided Assisted Surgery for Prostate Cancer (TRACE) Feasibility Study

Status
Unknown
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
The Netherlands Cancer Institute · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

PSMA-radioguided surgery

Detailed description

Given the difficulty visualizing lymph node involvement with pre-operative imaging alone, and the potential to miss metastatic nodal involvement on template PLND, radioguided surgery has been proposed as a technique to improve intra-operative detection and clearance. 99mTechnetium (99mTc) is a frequently used radioisotope in nuclear medicine, with favourable radiation properties and commercial availability\[11\]. It has a 6-hour half-life, and is suited to allow target tissue accumulation, while minimizing patients and investigator radiation exposure. Novel molecule-targeted radiopharmaceuticals using 99mTC and other radioisotopes in the setting of PC have increasing potential for diagnostic imaging, monitoring of therapeutic interventions and directed surgery\[11, 12\]. In relation to radioguided surgery, 99mTC -based PSMA-radioguided surgery (99mTc-PSMA-RGS) was deployed in a feasibility study. Using a specifically designed 99mTc based tracer, 99mTc-mas3-y-nal-k(Sub-KuE), or in short Tc-99m-PSMA I\&S, combined with a gamma probe, guidance of the surgical resection of recurrent PC lymph node metastases was undertaken in 132 patients, yielding a sensitivity of 84% and specificity of 100% and detecting metastases as small as 3mm\[15, 16\]. This raises the question as to whether a combination of PSMA PET/CT imaging and PSMA-radioguided surgery may increase the cure rate in patients undergoing operative management of PC, by increasing detection sensitivity and specificity of nodal metastases.

Conditions

Interventions

TypeNameDescription
PROCEDUREPSMA-radioguided surgeryPSMA-radioguided surgery

Timeline

Start date
2020-03-11
Primary completion
2022-03-01
Completion
2022-03-01
First posted
2019-02-27
Last updated
2020-07-22

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT03857113. Inclusion in this directory is not an endorsement.